Herbas VPB

Print
EN | LT
LT - COMBINATION OF ANTI-PD-1 ANTIBODIES AND RADIATION TO TREAT CANCER
EN - COMBINATION OF ANTI-PD-1 ANTIBODIES AND RADIATION TO TREAT CANCER

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28 (2006.01)
A61K 39/39541 (2013.01)
A61N 5/00 (2006.01)
C07K 16/2818 (2013.01)
A61N 5/10 (2006.01)
C07K 16/2878 (2013.01)
A61N2005/1098 (2013.01)
C07K2317/21 (2013.01)
C07K2317/76 (2013.01)
A61P 35/04 (2018.01)
A61P 35/00 (2018.01)
A61K 47/6849 (2017.08)
A61K2039/507 (2013.01)
A61K2039/505 (2013.01)
A61K2039/545 (2013.01)
European patent
(11) Number of the document 3455259
(13) Kind of document T
(96) European patent application number 17727767.0
Date of filing the European patent application 2017-05-12
(97) Date of publication of the European application 2019-03-20
(45) Date of publication and mention of the grant of the patent 2023-03-01
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2017/032397
Date 2017-05-12
PCT application publication
(87) Number WO 2017/197259
Date 2017-11-16
Priority applications
(30) Number Date Country code
201662335743 P 2016-05-13 US
201662340142 P 2016-05-23 US
201662348546 P 2016-06-10 US
201662350305 P 2016-06-15 US
201662364920 P 2016-07-21 US
201662374020 P 2016-08-12 US
201762451274 P 2017-01-27 US
Inventors
(72)
SKOKOS, Dimitris , US
LOWY, Israel , US
Grantee
(73) Regeneron Pharmaceuticals, Inc. , 777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Title
(54) COMBINATION OF ANTI-PD-1 ANTIBODIES AND RADIATION TO TREAT CANCER
  COMBINATION OF ANTI-PD-1 ANTIBODIES AND RADIATION TO TREAT CANCER